NSE/PIDILITIND

PIDILITINDPidilite Industries Ltd

Chemicals · NSE

₹1,393.4+4.69%

52-wk low52-WEEK RANGE52-wk high

₹1,273.6+9.4% from low ·-55.4% from high₹3,127

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

PIDILITIND-52.60% · 1Y

Range high ₹3,149.9Range low ₹1,259Latest ₹1,393.4252 bars · daily-close · NSE bhavcopy + 10Y history

ChemicalsSpecialty ChemicalsLargecapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite38/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -7.7% — underperformer
· Below 200-DMA (-5.2%) — downtrend

Valuation

High

Looks expensive vs the sector.

· P/E 62.0 — 62% above sector median 38.2
· P/B 14.82 above sector median

Growth

Medium

Steady but not standout growth.

· Revenue YoY +10.1%
· Profit YoY +11.8%

Profitability

High

Showing good signs of profitability & efficiency.

· ROE 23.9% — high-quality compounder
· Net margin 15.8% — strong pricing power

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeC(48/100)

Durability

A+

88/100

Financially resilient — strong quality + solvency profile.

Show 4 drivers

Piotroski F-score6/9 (67pt)
Altman Z" score6.20 (100pt)
Debt/Equity0.04 (100pt)
ROE23.9% (96pt)

Valuation

14/100

Richly valued on most axes; limited margin of safety.

Show 4 drivers

P/E vs sector (62.0 / 38.2)162% (28pt)
P/B14.82 (0pt)
Dividend yield0.72% (18pt)
EV/EBITDA43.2 (0pt)

Momentum

42/100

Momentum is muted; trend is unclear or rolling over.

Show 5 drivers

52w change-7.7% (35pt)
DMA-trend alignmentdown (25pt)
RSI (14)56.4 (99pt)
Price vs 200-DMA-27.9% (12pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)61.99

OVERVALUED

CheapestP/E 62.0 at 92th %ile — pricier than 92% of peers.Most expensive

P/B14.82

OVERVALUED

CheapestP/B 14.82 at 100th %ile of sector.Most expensive

EV/EBITDA43.22

OVERVALUED

Monthly seasonality

Avg monthly return over 11 years · historical — not a forecast

Best: Apr +12.99% · Worst: Sep -5.08%

Jan

-0.1%

36% win

Feb

+0.8%

75% win

Mar

+2.0%

83% win

Apr

+13.0%

83% win

May

+4.0%

64% win

Jun

-1.3%

Monthly return distribution

Distribution of 135 monthly returns

Mean

+1.81%

Median

+0.93%

Std dev

12.39%

Best

+113.0%

Worst

-51.9%

% positive

58%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 5

High-quality compounder (ROE 23.9%)
Above 20% ROE consistently flags capital-efficient businesses
Lean balance sheet (D/E 0.04)
Low leverage means earnings are less sensitive to rate cycles
Strong net margin (15.8%)
High margin indicates pricing power + operating efficiency
Bankruptcy risk low (Altman Z″ 6.20)
Z″ above 2.60 sits squarely in the 'safe' zone
Top quartile ROE in Chemicals
Rank 1 of 13 peers

WEAKNESSES · 1

Premium to sector on P/E (+62%)
P/E 62.0 vs Chemicals median 38.2

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 1

Valuation compression risk
P/E 62.0 is 62% above sector — any growth miss gets punished

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+4.7%

+2.7%

+4.0%

-7.2%

-5.6%

-52.5%

+5.6%

+9.7%

10Y

+16.8%

Fundamentals

VALUATION

Market cap

₹1,41,522 Cr

P/E (TTM)

62.0

P/E (fwd)

53.4

next 12m

P/B

14.82

EV/EBITDA

43.2

Book value

₹93.85

per share

PROFITABILITY · QUALITY

ROE

23.9%

ROCE

—

Net margin

15.8%

Op margin

21.4%

Gross margin

54.7%

D/E

0.04

GROWTH · MARKET

Rev YoY

+10.1%

Profit YoY

+11.8%

Div yield

0.72%

Payout

44.5%

52w change

-7.7%

Beta

0.35

defensive

Pros and cons

Auto-derived from ratios · not a buy/sell recommendation

PROS · 5

+Forward P/E materially below trailing (53.4x vs 62.0x)Street expects earnings growth that compresses the multiple — positive surprise cushion
+High ROE of 23.9%Capital-efficient business — every rupee of equity generates 23.9 paise of earnings
+Strong operating margin (21.4%)Meaningful pricing power or cost discipline — above many Indian companies
+Nearly debt-free (D/E 0.04)Low financial risk — funds growth from internal accruals, resilient in downturns
+Top-3 ROE in Chemicals sectorBest-in-class profitability among 13 listed peers

CONS · 2

−Trades at a premium to sector on P/EP/E 62.0 vs Chemicals median 38.2 — priced for more growth than peers
−Very high absolute P/E (62x)

Sector-relative context

Chemicals · 13 peers

P/E (TTM)

This stock

61.99

Sector median

38.18

Rank 12/13 (15th %ile)

ROE

This stock

23.9%

Sector median

13.4%

Rank 13/13 (8th %ile)

P/B

This stock

14.82

Sector median

4.34

Rank 13/13 (8th %ile)

Quality score · Piotroski F-score

6 / 9

Decent quality — clears Piotroski bar

✓Profitable (positive net income)· Most basic check — company makes money
✓Positive return on assets· Assets generate returns
✓Positive operating cash flow· Profits are backed by real cash, not accruals
✗Operating CF exceeds net profit· Healthy cash conversion — no aggressive revenue recognition
✗Long-term debt decreased YoY· Deleveraging — lower refinancing risk
✓ROA improved YoY· Getting more productive with the asset base
✓Operating margin expanded YoY· Pricing power or cost discipline
✗

Forensic score · Altman Z″ (emerging markets)

Bankruptcy-risk predictor · 1995 Altman emerging-market revision

SAFE6.20

Z″ = 6.20 — well inside the SAFE zone. Low bankruptcy risk signal across liquidity, profitability and solvency inputs.

Component	Ratio	Weight	Contribution
Working Capital / Total Assets (A)	0.335	×6.56	2.196
Retained Earnings / Total Assets (B)	0.518	×3.26	1.689
EBIT / Total Assets (C)	0.173	×6.72	1.162
Book Equity / Total Liabilities (D)	1.098	×1.05	1.153

Zones: Z″ ≥ 2.60 safe · 1.10–2.60 grey · < 1.10 distress. All four inputs derived from latest annual filing.

Analyst consensus

19 analysts · BUY

Target mean

₹1549.84

Target high

₹1915.00

Target low

₹1200.00

Upside vs today

+11.5%

Street consensus target is +11.5% vs current price. Consensus is a lagging sentiment read, not a forecast.

Company + balance sheet snapshot

Industry

Specialty Chemicals

Employees

8,153

Shares out

101.8

Revenue (TTM)

₹14,159 Cr

EBITDA

₹3,224 Cr

Total debt

₹443 Cr

Cash

₹3,185 Cr

Net debt

₹-2,743 Cr

Quarterly results

Last 5 quarters · ₹ Cr (Screener.in-grade depth)

Metric	2024-Q3	2024-Q4	2025-Q1	2025-Q2	2025-Q4
Revenue	3,235	3,369	3,095	3,753	3,710
Operating profit	681	709	556	844	793
OPM %	21.1%	21.0%	18.0%	22.5%	21.4%
Interest	12

Annual P&L

Last 4 years · ₹ Cr · all line items

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Revenue	9,880	11,752	12,337	13,094
Operating profit	1,645	1,752	2,403	2,675
OPM %	16.6%	14.9%	19.5%	20.4%
Interest	42	48	51	50

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
PIDILITINDTHIS Pidilite Industries Limited	₹1,393.4	-53.9%	1,41,522	62.0	14.82	23.9%	0.04	+10.1%
SRF SRF Limited	₹2,494.5	-17.7%	73,067	41.0	5.51	13.4%	0.35	+6.3%
COROMANDEL Coromandel International Limited	₹2,050.2	-6.7%	60,568	25.3	4.97	19.6%	0.12	+9.2%
PIIND PI Industries Limited	₹3,139.7	-14.8%	47,028	32.4	4.34	—	0.02	+4.1%
NAVINFLUOR Navin Fluorine International Limited	₹6,284	+49.1%	32,747	59.0	9.05	—	0.33	+13.8%
DEEPAKNTR Deepak Nitrite Limited	₹1,538.1	-23.8%	20,767	39.0	3.76	9.7%	0.22	+204.0%
ATUL Atul Limited	₹6,600	+10.5%	19,356	32.6	3.27	10.1%	0.03	+18.1%
AARTIIND Aarti Industries Limited	₹440.85	+4.6%	16,067	42.6	2.82	6.6%	0.70	+14.1%
FINEORG Fine Organic Industries Limited	₹4,907.5	+13.9%	14,852	37.4	6.00	16.0%	0.01	+13.0%

ASK AXEL

Dig deeper into PIDILITIND

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for PIDILITIND — all in one sourced reply.

Ask free in chat

Run these tools on PIDILITIND

Historical return →

"If I had bought PIDILITIND in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on PIDILITIND

Brokerage + charges →

All-in cost for trading PIDILITIND

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Quarter	EPS estimate	EPS actual	Surprise %
-1q	6.08	6.10	+0.4%
-2q	8.08	5.68	-29.8%
-3q	6.19	6.59	+6.5%
-4q	4.29	4.33	+0.9%

Date	Amount
2025-07-23	₹10.00
2024-07-24	₹8.00
2023-07-27	₹5.50
2022-07-26	₹5.00
2021-07-27	₹4.25
2020-03-13	₹3.50
2019-07-29	₹3.25
2018-08-21	₹3.00
2017-08-23	₹2.38
2016-08-24	₹0.25

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Equity capital	51	51	51	51
Reserves	4,929	5,708	6,816	8,072
Borrowings	416	391	382	454
Total liabilities	9,516	10,525	12,104	14,011
Fixed assets	2,016	2,438	2,732	2,988
CWIP	258	437	177	152
Investments	234	255	260	294
Other assets	55	51	48	49
Total assets	9,516	10,525	12,104	14,011

Metric	2022-FY	2023-FY	2024-FY	2025-FY
CF Operating	955	1,558	2,724	2,287
CF Investing	-558	-899	-1,769	-1,542
CF Financing	-468	-656	-742	-918
Net cash flow	-71	2	201	-172
Free cash flow	581	1,052	2,165	1,834

Metric	2025-FY	2024-FY	2023-FY	2022-FY
OPM %	20.4%	19.5%	14.9%	16.6%
Net margin %	15.9%	14.0%	10.8%	12.2%
ROE %	27.7%	27.4%	23.7%	24.3%
ROCE %	36.3%	36.3%	30.7%	30.7%
Debt / Equity	0.06	0.06	0.07	0.08
Dividend payout %	39%	32%	40%	36%
Interest coverage	57.1×	47.5×	37.2×	39.4×
Revenue growth YoY	+6.1%	+5.0%	+18.9%	—
Profit growth YoY	+20.1%	+35.8%	+5.4%	—

PIDILITINDPidilite Industries Ltd

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Analyst consensus

Company + balance sheet snapshot

Quarterly results

Annual P&L

Peer comparison · Chemicals

Ask Axel about PIDILITIND

Recent news

Dig deeper into PIDILITIND

Run these tools on PIDILITIND

Technical snapshot

Earnings history + surprises

Dividends + splits history

Recent news

Stock scorecard

SWOT analysis

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Analyst consensus

Company + balance sheet snapshot

Quarterly results

Annual P&L

Balance sheet

Cash flow statement

Ratios

Peer comparison · Chemicals